AP2011005739A0 - An expression vector and processes thereof. - Google Patents

An expression vector and processes thereof.

Info

Publication number
AP2011005739A0
AP2011005739A0 AP2011005739A AP2011005739A AP2011005739A0 AP 2011005739 A0 AP2011005739 A0 AP 2011005739A0 AP 2011005739 A AP2011005739 A AP 2011005739A AP 2011005739 A AP2011005739 A AP 2011005739A AP 2011005739 A0 AP2011005739 A0 AP 2011005739A0
Authority
AP
ARIPO
Prior art keywords
processes
expression vector
vector
expression
Prior art date
Application number
AP2011005739A
Inventor
Sunil Shekar
Villoo Morawala Patell
Original Assignee
Avesthagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avesthagen Ltd filed Critical Avesthagen Ltd
Publication of AP2011005739A0 publication Critical patent/AP2011005739A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
AP2011005739A 2008-10-28 2009-10-23 An expression vector and processes thereof. AP2011005739A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2614CH2008 2008-10-28
PCT/IB2009/007207 WO2010049777A1 (en) 2008-10-28 2009-10-23 An expression vector and processes thereof

Publications (1)

Publication Number Publication Date
AP2011005739A0 true AP2011005739A0 (en) 2011-06-30

Family

ID=42128314

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005739A AP2011005739A0 (en) 2008-10-28 2009-10-23 An expression vector and processes thereof.

Country Status (7)

Country Link
EP (1) EP2362911A4 (en)
CN (1) CN102257141A (en)
AP (1) AP2011005739A0 (en)
AU (1) AU2009309387A1 (en)
BR (1) BRPI0914484A2 (en)
WO (1) WO2010049777A1 (en)
ZA (1) ZA201103960B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011015924A2 (en) * 2009-08-03 2011-02-10 Avesthagen Limited Vectors and compounds for expression of recombinant trastuzumab
WO2011015917A2 (en) * 2009-08-03 2011-02-10 Avesthagen Limited Vectors and compounds for expression of recombinant tnk-tpa (tenecteplase)
WO2011015918A2 (en) * 2009-08-03 2011-02-10 Avesthagen Limited Vectors and compounds for expression of recombinant cetuximab
WO2011015916A2 (en) * 2009-08-03 2011-02-10 Avesthagen Limited Vectors and compounds for expression of recombinant infliximab
EP2729573B1 (en) * 2011-07-08 2018-02-14 Cilbiotech S.A. A transgenic system for reversibly immortalizing mammalian quiescent cells
WO2014120975A1 (en) 2013-02-01 2014-08-07 California Institute Of Technology Antibody-mediated immunocontraception
US10966414B2 (en) 2015-05-26 2021-04-06 California Institute Of Technology Population control using engineered translocations
US11965172B2 (en) 2018-11-05 2024-04-23 California Institute Of Technology DNA sequence modification-based gene drive

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP1395669B1 (en) * 2001-01-26 2009-07-22 Selexis S.A. Matrix attachment regions and methods for use thereof
US7541512B2 (en) * 2001-03-30 2009-06-02 Synageva Biopharma Corp. Avians containing a lysozyme promoter transgene
ATE514783T1 (en) * 2003-11-12 2011-07-15 Schering Corp PLASMID SYSTEM FOR EXPRESSING MULTIPLE GENES
RU2469089C2 (en) * 2006-08-23 2012-12-10 Селексис С.А. Expression system for increasing gene expression level, nucleic acid molecule, transgenic animal and kit
EP2331693A2 (en) * 2008-08-12 2011-06-15 Avesthagen Limited An expression vector and a method thereof

Also Published As

Publication number Publication date
AU2009309387A1 (en) 2010-05-06
BRPI0914484A2 (en) 2015-09-01
CN102257141A (en) 2011-11-23
WO2010049777A1 (en) 2010-05-06
EP2362911A1 (en) 2011-09-07
EP2362911A4 (en) 2012-07-18
ZA201103960B (en) 2012-03-28

Similar Documents

Publication Publication Date Title
AP2011005754A0 (en) Processing biomas.
GB0917044D0 (en) Agents, uses and methods
GB0917054D0 (en) Agents, uses and methods
HK1163587A1 (en) Process, dispersions and use
IL219882A0 (en) System for increasing gene expression and vector comprising the system
IL210804A (en) Benzylidenehydrazides and uses thereof
HK1183435A1 (en) Frizzled-binding agents and uses thereof
AP2011005821A0 (en) Processing biomas.
HUE059436T2 (en) Psma-binding agents and uses thereof
EP2313498A4 (en) Recognition sequences for i-crei-derived meganucleases and uses thereof
EP2234104A4 (en) Vector quantizer, vector inverse quantizer, and methods therefor
GB0810912D0 (en) Vector
PT2274422T (en) Expression vector
AP2011005739A0 (en) An expression vector and processes thereof.
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
ZA201101882B (en) An expression vector and a method thereof
GB0820631D0 (en) Vectors
PL2247601T3 (en) Thiazopyrimidinones and uses thereof
GB0817998D0 (en) Process,dispersions and use
EP2285827A4 (en) Peptides and uses thereof
GB0810154D0 (en) Expression vector
EP2345660A4 (en) Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent
GB2461240A9 (en) Alloy.
GB0813359D0 (en) Halfin and/or platerfin